LATEST NEWS

LJI scientists lead pandemic preparedness as they develop strategies for stopping rodent-borne viruses
LJI scientists discover how we can harness T cells to combat deadly infections, including Lassa fever and hantavirus disease
Prebys Foundation celebrates ground-breaking female researchers
LJI President and CEO celebrated among California’s leading life sciences innovators
New Merkin Fellowship to support U.K. collaboration on Lassa virus research
Three rare antibodies, combined in a "cocktail," are effective in fighting Lassa virus
New study shows how new therapies might target Lassa and Ebola viruses
Adrian Enriquez, Ph.D., has a different way of looking at viruses
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
Detailed structural studies provide blueprint for the development of potent therapeutics and vaccines